おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Pepgen
company
About
Pepgen is a privately-held biopharmaceutical company that develops novel products for the treatment of autoimmune and viral disorders.
- 1 - 10
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $7.50M
- Industries
- Biopharma,Medical,Pharmaceutical
- Founded date
- Jan 1, 1992
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Pepgen is a privately-held biopharmaceutical company that develops and commercializes novel products for the prevention and treatment of autoimmune and viral disorders.It was founded in 1992 by Chih-Ping Liu and is based in Alameda, California.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$7.50M
Pepgen has raised a total of
$7.50M
in funding over 2 rounds. Their latest funding was raised on
Aug 3, 2004 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 3, 2004 | Series D | $7.50M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Pepgen is funded by 2 investors.
Biotechnology Development Fund VI, L.P.
and Veron International
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series D |
|
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
